Remdesivir, a non-specific antiviral drug that was originally tested against Ebola, has been shown to be effective against the new coronavirus in a preliminary data analysis, as reported by the National Institutes of Health. The UW School of Medicine was one of the sites in the National Institutes of Health trial. Dr.
Researchers have been studying COVID-19 in homeless communities, specifically in shelters with two or more confirmed cases in the weeks prior to their study. They found that in these shelters with clusters of cases, the proportion of positive tests was higher than in shelters with lower amounts of previously reported cases.
The University of Washington Population Health Initiative recently awarded 21 rapid response grants to study COVID-19. Four of these grants include faculty members from the Department of Global Health – Deepa Rao, Kristina Adams Waldorf, Bryan Weiner, and James Mullins.
by Ruanne Barnabas, Associate Professor, UW Global Health
The following links are a collection of news stories about the coronavirus that either quote, include, or were written by Department of Global Health faculty and staff. This includes video interviews with local and national media outlets, as well as written stories detailing DGH's research and innovation in fighting COVID-19.
Also see UW School of Public Health's web pages on Coronavirus Response, Resources and News
Each year the Department of Global Health invites organizations to campus for our annual career fair to talk with our students about working in global and local health during Global Health Career Week. This year we are doing something a bit different and have invited a number of our regular fair participants to each host an hour long ZOOM session where they might present information on their organization, their work, the culture of hiring, job or internship opportunities that might arise, and how students might best prepare for these session.
As the global COVID-19 pandemic spreads, there are increasing numbers of cases in low- and middle-income country (LMIC) settings, including in many African countries. A new $1.38 million UW research project funded by the Bill and Melinda Gates Foundation will monitor the spread of COVID-19 in sites in Africa in order to increase understanding of the effects of COVID-19 on vulnerable children and adults, healthcare workers and researchers in low-resource settings.
The American Academy of Arts & Sciences today announced its 2020 class of new members, including Fred Hutchinson Cancer Research Center‘s Dr. Julie Overbaugh, who studies factors that shape HIV transmission.
Researchers at the University of Washington on Friday announced a major new study of the malaria drug President Donald Trump has praised as a possible, low-cost cure for COVID-19.
The clinical trial is one of dozens around the world aimed at providing definitive evidence about the effectiveness of hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, against the novel coronavirus.
Trial is looking at effectiveness of hydroxychloroquine with and without azithromycin. Results expected by July.
Researchers are now enrolling outpatients with COVID-19 for a randomized controlled trial of the effectiveness of two drug regimens – hydroxychloroquine and hydroxychloroquine with azithromycin.